Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896520435> ?p ?o ?g. }
- W2896520435 endingPage "577" @default.
- W2896520435 startingPage "566" @default.
- W2896520435 abstract "In the absence of randomized clinical trial data, questions remain regarding the optimal treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections. CRE have historically been susceptible to polymyxins, tigecycline or aminoglycosides (mostly gentamicin), and these antibiotics have long been considered the drugs of choice for CRE infections, although varying rates of resistance to all have been reported. This review looks at data from clinical studies assessing the outcomes of CRE infections treated with different antibiotic regimens.The recently approved fixed-dose combination agent, ceftazidime-avibactam (CAZ-AVI), is active against KPC and OXA-48-producing Enterobacteriaceae. The limited clinical data available on CAZ-AVI indicate that it is associated with survival benefits relative to other commonly used regimens, although development of resistance is a concern. New drugs active against CRE isolates (including the recently approved meropenem-vaborbactam) are in different stages of development.CAZ-AVI and meropenem-vaborbactam seem destined to become the backbone of target therapy for high-risk patients with severe infections caused by susceptible CRE strains. However, empirical therapy should be based on risk factors to be defined in the near future, whereas the necessity of combinations with CAZ-AVI requires further studies. Polymyxins are still important options for low-risk patients with susceptible CRE infections, but also for high-risk patients in regions where metallo-β-lactamase-producing CRE predominate because CAZ-AVI and meropenem-vaborbactam are both ineffective against these strains." @default.
- W2896520435 created "2018-10-26" @default.
- W2896520435 creator A5052146006 @default.
- W2896520435 creator A5065316372 @default.
- W2896520435 creator A5070607915 @default.
- W2896520435 date "2018-12-01" @default.
- W2896520435 modified "2023-10-16" @default.
- W2896520435 title "Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections" @default.
- W2896520435 cites W1433753708 @default.
- W2896520435 cites W1548936307 @default.
- W2896520435 cites W1606853044 @default.
- W2896520435 cites W1612376079 @default.
- W2896520435 cites W1804516907 @default.
- W2896520435 cites W1833417126 @default.
- W2896520435 cites W1891727612 @default.
- W2896520435 cites W1903855728 @default.
- W2896520435 cites W1955380492 @default.
- W2896520435 cites W1956837549 @default.
- W2896520435 cites W1977371637 @default.
- W2896520435 cites W1978370571 @default.
- W2896520435 cites W1987333947 @default.
- W2896520435 cites W1992531025 @default.
- W2896520435 cites W1998219716 @default.
- W2896520435 cites W2004338062 @default.
- W2896520435 cites W2015816720 @default.
- W2896520435 cites W2017310905 @default.
- W2896520435 cites W2017352107 @default.
- W2896520435 cites W2021439166 @default.
- W2896520435 cites W2028117275 @default.
- W2896520435 cites W2028365252 @default.
- W2896520435 cites W2028494881 @default.
- W2896520435 cites W2035208320 @default.
- W2896520435 cites W2036173518 @default.
- W2896520435 cites W2042164350 @default.
- W2896520435 cites W2043639362 @default.
- W2896520435 cites W2046443423 @default.
- W2896520435 cites W2052288044 @default.
- W2896520435 cites W2064648176 @default.
- W2896520435 cites W2072361904 @default.
- W2896520435 cites W2089928475 @default.
- W2896520435 cites W2099249152 @default.
- W2896520435 cites W2103549535 @default.
- W2896520435 cites W2130614349 @default.
- W2896520435 cites W2134744238 @default.
- W2896520435 cites W2148052544 @default.
- W2896520435 cites W2156467434 @default.
- W2896520435 cites W2164697816 @default.
- W2896520435 cites W2166505398 @default.
- W2896520435 cites W2170001997 @default.
- W2896520435 cites W2179036997 @default.
- W2896520435 cites W2245659112 @default.
- W2896520435 cites W2259621518 @default.
- W2896520435 cites W2266932982 @default.
- W2896520435 cites W2274400035 @default.
- W2896520435 cites W2282410181 @default.
- W2896520435 cites W2285087135 @default.
- W2896520435 cites W2336585894 @default.
- W2896520435 cites W2336621586 @default.
- W2896520435 cites W2338106090 @default.
- W2896520435 cites W2408536099 @default.
- W2896520435 cites W2409379438 @default.
- W2896520435 cites W2466109315 @default.
- W2896520435 cites W2470769425 @default.
- W2896520435 cites W2483207560 @default.
- W2896520435 cites W2497057717 @default.
- W2896520435 cites W2509216003 @default.
- W2896520435 cites W2513238037 @default.
- W2896520435 cites W2517923973 @default.
- W2896520435 cites W2519197882 @default.
- W2896520435 cites W2519911390 @default.
- W2896520435 cites W2520256066 @default.
- W2896520435 cites W2527977895 @default.
- W2896520435 cites W2537910475 @default.
- W2896520435 cites W2548338486 @default.
- W2896520435 cites W2548586488 @default.
- W2896520435 cites W2548683746 @default.
- W2896520435 cites W2556880340 @default.
- W2896520435 cites W2559621415 @default.
- W2896520435 cites W2560013005 @default.
- W2896520435 cites W2573063008 @default.
- W2896520435 cites W2574619611 @default.
- W2896520435 cites W2587091458 @default.
- W2896520435 cites W2588359012 @default.
- W2896520435 cites W2600586474 @default.
- W2896520435 cites W2604389227 @default.
- W2896520435 cites W2604542158 @default.
- W2896520435 cites W2605062914 @default.
- W2896520435 cites W2605140625 @default.
- W2896520435 cites W2607050795 @default.
- W2896520435 cites W2620061440 @default.
- W2896520435 cites W2621162085 @default.
- W2896520435 cites W2727512727 @default.
- W2896520435 cites W2741319514 @default.
- W2896520435 cites W2741625403 @default.
- W2896520435 cites W2744408422 @default.
- W2896520435 cites W2748148697 @default.
- W2896520435 cites W2751939257 @default.
- W2896520435 cites W2753535979 @default.